Head to head
IBM Corp vs Accenture
Side-by-side on the measures that matter, with a plain-English read. Full detail: IBM · ACN
IBM
IBM Corp
227.13+0.23%
1-year price shape — -19% over the period
Quant Rating D · 20/100
vs
ACN
Accenture
209.06+0.34%
1-year price shape — -14% over the period
Quant Rating D · 24/100
1-year performance, rebased to 100
Accenture edges it on the scoreable measures. Accenture has the highest Quant Rating (24); Accenture has done best over the past year (-14%); Accenture trades cheapest on trailing earnings.
| IBM | ACN | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Information Technology Services |
| Last price | 227.13 | 209.06 |
| Change today | +0.23% | +0.34% |
| 1-year return | -19.1% | -14.3% |
| Market cap | $213.99B | $124.60B |
| 52-week range | 197.77 – 330.09 | 116.75 – 285.21 |
| Valuation | ||
| P/E (TTM) | 20.12 | 15.42 |
| P/E percentile, own 5-yr range | 8th | 5th |
| P/B | 6.21 | 3.95 |
| Dividend yield | 2.96% | 3.12% |
| Profitability & growth | ||
| EPS (TTM) | 11.17 | 13.56 |
| Net profit (TTM) | $10.52B | $8.08B |
| Revenue (TTM) | $69.10B | $74.18B |
| Revenue growth (YoY) | +1.1% | +6.2% |
| Gross margin | 58.1% | 32.0% |
| Operating margin | 18.4% | 15.4% |
| Net margin | 15.5% | 11.3% |
| Free cash flow (TTM) | $13.14B | $11.62B |
| Ownership & sentiment | ||
| Institutional ownership | 66.3% | 83.9% |
| Insider activity (12mo) | 47 buy / 3 sell | 48 buy / 2 sell |
| Short interest (% of float) | 2.6% | 3.2% |
| Analyst consensus | 63% buy / 32% hold / 5% sell (19) | 50% buy / 50% hold (20) |
| Analyst price target | $256 (+13%) | $225 (+7%) |
| StockVane view | ||
| StockVane Quant Rating | D (20) | D (24) |
| Company | ||
| Employees | 286,800 | 779,000 |
| Founded | 1911 | 1989 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.